Breaking News Instant updates and real-time market news.

TRUE

TrueCar

$6.53

-0.23 (-3.40%)

07:19
03/25/19
03/25
07:19
03/25/19
07:19

TrueCar downgraded to Hold on management credibility issues at Benchmark

As previously reported, Benchmark analyst Daniel Kurnos downgraded TrueCar to Hold from Buy, stating that he believes it may take several quarters for management to regain credibility, with each quarter heavily scrutinized along the way. Kurnos said his rating change is "not a call on any expected further near-term deterioration in operating trends," though he is not anticipating "some miraculous turnaround either."

  • 28

    May

TRUE TrueCar
$6.53

-0.23 (-3.40%)

02/15/19
BNCH
02/15/19
NO CHANGE
Target $11
BNCH
Buy
TrueCar price target lowered to $11 from $16 at Benchmark
Benchmark analyst Daniel Kurnos said TrueCar's soft Q4 results and 2019 revenue guidance "finally proved the skeptics right," though he thinks that the majority of the negative news is now out in the open. While USAA negotiations remain a major risk, he believes a lack of options for both parties limits the likelihood of "a major blowup." Kurnos keeps a Buy rating on TrueCar, though he cut his price target on the stock to $11 from $16 and admits "perhaps we're missing our chance to get off the bus a stop too late."
02/15/19
CHLM
02/15/19
DOWNGRADE
Target $10
CHLM
Hold
TrueCar downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Steve Dyer downgraded TrueCar to Hold from Buy and lowered his price target to $10 from $14 following weak results and guidance. In a research note to investors, Dyer says he remains optimistic on the company's product pipeline and long-term stock opportunity, but he thinks shares will be range bound for the next several quarters as near-term challenges and limited visibility will be an overhang on shares. Dyer thinks 2019 will be another year of product development and execution, and the fundamental inflection with revenue growth reacceleration and meaningful margin expansion is likely a 2020 event.
03/18/19
GSCO
03/18/19
INITIATION
Target $6
GSCO
Sell
TrueCar assumed with a Sell at Goldman Sachs
Goldman Sachs analyst Daniel Powell assumed coverage of TrueCar from analyst Heath Terry and maintained a Sell rating on the shares. He reduced the stock's price target to $6 from $7. Google search updates negatively impacted traffic growth in Q4 and the company expects continued pressure on traffic as it works to adjust its landing pages and user interface to adapt, Powell tells investors in a research note. The implications of slower spend growth amid structural challenges in traffic acquisition could disrupt long-term growth, Powell tells investors in a research note.
03/25/19
BNCH
03/25/19
DOWNGRADE
BNCH
Hold
TrueCar downgraded to Hold from Buy at Benchmark

TODAY'S FREE FLY STORIES

WST

West Pharmaceutical

$146.32

-0.14 (-0.10%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Hot Stocks
West Pharmaceutical announces 848K share repurchase authorization »

On December 10, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Earnings
Amarin sees FY20 revenue $650M-$700M, consensus $654.55M »

With respect to 2020,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

IBIO

iBio

$0.22

-0.0179 (-7.43%)

17:01
12/13/19
12/13
17:01
12/13/19
17:01
Hot Stocks
iBio receives NYSE noncompliance notice »

iBio, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$21.23

0.29 (1.38%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Syndicate
Breaking Syndicate news story on Applied Therapeutics »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Earnings
Amarin raises FY19 revenue view to $410M-$425M from $380M-$420M 

FY19 consensus $410.25M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BIO

Bio-Rad

$354.69

-8.005 (-2.21%)

16:56
12/13/19
12/13
16:56
12/13/19
16:56
Hot Stocks
Bio-Rad progressing from ransomware attack recovery detected on Dec 5th »

Bio-Rad Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:50
12/13/19
12/13
16:50
12/13/19
16:50
Hot Stocks
Amarin confirms FDA approval of Vascepa »

Amarin announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

FRTA

Forterra

$10.69

0.11 (1.04%)

16:46
12/13/19
12/13
16:46
12/13/19
16:46
Syndicate
Breaking Syndicate news story on Forterra »

Forterra files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:45
12/13/19
12/13
16:45
12/13/19
16:45
Hot Stocks
Amarin receives FDA approval of Vascepa »

The U.S. FDA approved the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

, SPX

S&P 500

$0.00

(0.00%)

16:37
12/13/19
12/13
16:37
12/13/19
16:37
Periodicals
SCOTUS to hear three cases on Trump's financial records, CNBC reports »

The U.S. Supreme Court…

SPY

SPDR S&P 500 ETF Trust

$317.27

0.13 (0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$204.61

1.47 (0.72%)

16:34
12/13/19
12/13
16:34
12/13/19
16:34
Hot Stocks
CME Group CEO Duffy sells 39,309 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GLG

China Bat Group

$1.81

-0.055 (-2.95%)

16:33
12/13/19
12/13
16:33
12/13/19
16:33
Hot Stocks
China Bat Group regains compliance with Nasdaq »

China Bat Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

16:32
12/13/19
12/13
16:32
12/13/19
16:32
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HZNP

Horizon Pharma

$32.84

(0.00%)

16:30
12/13/19
12/13
16:30
12/13/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

16:30
12/13/19
12/13
16:30
12/13/19
16:30
Options
Preliminary option volume of 31.3M today »

Preliminary option volume…

ORCL

Oracle

$54.49

-1.98 (-3.51%)

, ADBE

Adobe

$316.89

11.13 (3.64%)

16:27
12/13/19
12/13
16:27
12/13/19
16:27
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks were on a…

ORCL

Oracle

$54.49

-1.98 (-3.51%)

ADBE

Adobe

$316.89

11.13 (3.64%)

RBS

RBS

$6.81

0.65 (10.55%)

BCS

Barclays

$9.73

0.65 (7.16%)

LYG

Lloyds Banking

$3.43

0.235 (7.37%)

T

AT&T

$38.24

-0.11 (-0.29%)

LYV

Live Nation

$64.23

-5.21 (-7.50%)

SRPT

Sarepta

$132.00

31.61 (31.49%)

TNDM

TNDM

ATNX

Athenex

$14.56

-2.38 (-14.05%)

AVGO

Broadcom

$315.37

-12.02 (-3.67%)

COST

Costco

$291.88

-5.62 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 29

    Jan

  • 05

    Mar

VKTX

Viking Therapeutics

$7.94

0.045 (0.57%)

16:26
12/13/19
12/13
16:26
12/13/19
16:26
Conference/Events
Viking Therapeutics management to meet with SVB Leerink »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

VCYT

Veracyte

$28.50

-0.16 (-0.56%)

16:24
12/13/19
12/13
16:24
12/13/19
16:24
Conference/Events
Veracyte management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

MCK

McKesson

$140.56

-3.44 (-2.39%)

16:21
12/13/19
12/13
16:21
12/13/19
16:21
Conference/Events
McKessonto hold a sell-side analyst meeting »

Sell-Side Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MDR

McDermott

$0.82

0.0412 (5.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Hot Stocks
McDermott discloses NYSE delisting notice »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.26

-1.52 (-1.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 26

    Mar

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 13th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPWR

Ideal Power

$2.45

0.04 (1.66%)

16:19
12/13/19
12/13
16:19
12/13/19
16:19
Syndicate
Breaking Syndicate news story on Ideal Power »

Ideal Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIE

Erie Indemnity

$168.97

0.25 (0.15%)

16:18
12/13/19
12/13
16:18
12/13/19
16:18
Hot Stocks
Erie Indemnity increases quarterly dividend »

The board of Erie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ESRT

Empire State Realty

$13.68

0.055 (0.40%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Empire State Realty renews $500M stock repurchase program »

Empire State Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.